Design and control of a low-cost non-backdrivable end-effector upper limb rehabilitation device.
Fulan Li, Yunfei Guo, Wenda Xu and 5 others
PMID 39678125WHAT IT FOUND
A low-cost upper limb robot moved its handle within 0.012 mm of set paths in tests on one healthy engineer.
It offers passive, active and game modes, but no stroke patients were treated.
Key findings
01The experiments used only one healthy engineer and did not include clinical research or human factors research involving multiple participants.
02In Powered Mode, one healthy subject followed four trajectories with an average mean absolute error of 0.012 mm between intended and recorded end-effector positions.
03Transparent Mode accurately simulated objects from 10 kg to 30 kg, but objects of 5 kg or less showed larger velocity errors because of motor acceleration limits.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The tests used one healthy engineer, not stroke patients or people with arm impairment. The study was exempt from IRB review because it was initial design and functionality testing, not clinical research or human factors research with multiple participants. No clinical outcomes were measured, so it cannot show effects on arm function, pain, fatigue, independence or recovery. There was no comparison with conventional therapy, another robot, or a control condition. There was no randomisation, blinding, allocation concealment, or dropout analysis because this was not a clinical trial. The reported errors are machine position errors, not patient movement errors or therapy dose.
Declared interests
The authors declared no financial support for the research, authorship, or publication.
The easy way to misread this
Do not conclude that this device improves stroke arm rehabilitation. The accuracy numbers come from tests on one healthy engineer, and no stroke patients or clinical outcomes were included.